Posizioni attive di Bradley Hodges
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Prothelia, Inc.
 Prothelia, Inc. BiotechnologyHealth Technology Prothelia, Inc. operates as a biotechnological company that engages in the provision of protein therapy. It focuses on the treatment of congenital muscular dystrophy type 1A. The company was founded by Bradley Hodges and is headquartered in Milford, MA. | Direttore Tecnico/Scientifico/R&S | 01/10/2007 | - |
| Fondatore | 01/10/2007 | - | |
CureDuchenne Ventures LLC
 CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures LLC (CureDuchenne Ventures) is a venture capital subsidiary of CureDuchenne, founded in 2014 by Debra Miller. The firm is headquartered in Newport Beach, California. | Investitore di Private Equity | 01/05/2022 | - |
Storia della carriera di Bradley Hodges
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Private Equity Investor | 1 |
Settori
| Finance | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
CureDuchenne Ventures LLC
CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures LLC (CureDuchenne Ventures) is a venture capital subsidiary of CureDuchenne, founded in 2014 by Debra Miller. The firm is headquartered in Newport Beach, California. | Finance |
Prothelia, Inc.
Prothelia, Inc. BiotechnologyHealth Technology Prothelia, Inc. operates as a biotechnological company that engages in the provision of protein therapy. It focuses on the treatment of congenital muscular dystrophy type 1A. The company was founded by Bradley Hodges and is headquartered in Milford, MA. | Health Technology |
- Borsa valori
- Insiders
- Bradley Hodges
- Esperienza
